2 Aug 2012 12:12
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying Silence Therapeutics plc issuer of existing shares to which voting rights are attached: ii
2 Reason for the notification (please tick the appropriate box or boxes):An acquisition or disposal of voting rightsAn acquisition or disposal of qualifying financial instruments which mayresult in the acquisition of shares already issued to which votingrights are attachedAn acquisition or disposal of instruments with similar economic effectto qualifying financial instrumentsAn event changing the breakdown of voting rightsOther (please specify):
3. Full name of person(s) subject to the Simpson Financial Limited notification obligation: iii
4. Full name of shareholder(s) (ifdifferent from 3.):iv5. Date of the transaction and date on 2 August 2012which the threshold is crossed orreached: v6. Date on which issuer notified: 2 August 20127. Threshold(s) that is/are crossed or below 3%
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ixClass/type of Situation previous to Resulting situation after the triggeringshares if the triggering transactionpossible using transactionthe ISIN CODE Number of Number of Number of Number of voting % of voting rights Shares Voting shares rights x Rights Direct xi Direct Indirect Direct Indirect xiiGB0008433350 25,000,000 25,000,000 33,073,055 33,073,055 2.26%B: Qualifying Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration Exercise/ Number of voting % of votinginstrument date xiii Conversion Period rights that may be rights xiv acquired if the instrument is exercised/ converted.N/AC: Financial Instruments with similar economic effect to Qualifying Financial Instrumentsxv, xviResulting situation after the triggering transactionType of Exercise Expiration Exercise/ Number of voting % of voting rightsfinancial price date xvii Conversion rights instrument xix, xxinstrument period refers to xviiiN/A Nominal Delta Total (A+B+C)Number of voting rights Percentage of voting rights33,073,055 2.26%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to holdvoting rights:13. Additional information:14. Contact name: Eric K. Simpson15. Contact telephone number: 852 2520 2066
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation Full name (including legal form of legal Simpson Financial Limited entities) Contact address (registered office for Wyndham Place 26th Floor, 44 Wyndham legal entities)
Street, Central, Hong KongPhone number & email 852 2520 2066 sfl@simpsonfinancial.comOther useful information (at least legalrepresentative for legal persons)B: Identity of the notifier, if applicableFull nameContact addressPhone number & emailOther useful information (e.g. functionalrelationship with the person or legalentity subject to the notificationobligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
XLON